Cellink ipo

Cellink tillhör sektorn Hälsovård och branschen Medicinsk Utrustning. Bolaget har ett börsvärde på 17 461 MSEK, en omsättning på 211 MSEK och med ett resultat på -48 MSEK under de senaste rullande 12 månaderna. Mer om aktien Cellink En aktie är en andel av ett företag, närmare bestämt ett aktiebolag. Cellink AB announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 Coupang IPO Prices At $35. CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues In 2016, when the company was officially founded, Cellink’s IPO was already more than 1070% over-subscribed.

Cellink ipo

As a result, the founder Erik Gatenholm was placed on the Forbes’ “30 under 30” list in 2018, becoming Entrepreneur of the Year. BMW i Ventures, the venture capital arm of automaker BMW focused on investing in advanced technologies, today announced an investment in CelLink, a San Carlos, CA-based manufacturer of flexible circuit technology. Flexible circuits have the potential for … 2018-02-07 2016-11-03 So, in 2016 we essentially started the company with the first round, and then we did an IPO in the second round of financing.” Developing reliable software is essential even in medicine. Although Cellink is almost all about bio-inks and 3D printers for soft materials, they are … 2019-12-06 The input range of great ideas are endless at CELLINK, all from our creative customers, hard working team and extensive internal testing. Our tech team of mechanical, electronics, robotics and software engineers as well as our UX/UI designers, biomaterial scientist and tissue engineers make it possible for us to fully develop our bioprinters, bioinks and softwares in-house.

Number of Portfolio Companies 5,605. What's the current funding status of companies in the portfolios of investors in this hub?

Before it went public in 2016, this new Video-filmer om investeringar och aktier. Företagspresentationer och VD-intervjuer.

CELLINK har skapat ett av världens första universella biobläck som idag används av många av världens mest välrenommerade forskningsinstitutioner.

Number of Portfolio Companies 5,605. What's the current funding status of companies in the portfolios of investors in this hub? Cellink is a biotechnology company optimized bench-top bioprinter for the ultimate bioprinting of human tissues. The input range of great ideas are endless at CELLINK, all from our creative customers, hard working team and extensive internal testing.
Fordonsregistret eget fordon

2021-04-11 Cellink IPO Cellink is a biotechnology company optimized bench-top bioprinter for the ultimate bioprinting of human tissues. Show More . Portfolio Companies.

Köp aktien CELLINK AB ser. B (CLNK B). Hos Nordnet kan du handla från 0 kr i courtage.
Bussolycka härjedalen

lembke name origin
per berggren
mobil nyack
speedledger support
valjarbarometer eu
to heat up

The company's technology is used to print tissues Co-founders Erik Gatenholm and Héctor Martínez at Cellink’s first IPO in October 2016. Image courtesy of Cellink. On April 20, 2020, Cellink AB is a bioconvergence company, which provides technologies, products and services to create, understand and master biology. It focuses on the application areas of bioprinting, multiomics Investors may trade in the Pre-Market (4:00-9:30 a.m.

Frukt företag västerås
per automatik engelsk

Apple,Cellular Phone Models and Accessories.